false 0000914139 0000914139 2025-01-30 2025-01-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________
FORM 8-K
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of earliest event reported): January 30, 2025
 
PARKERVISION, INC.
(Exact Name of Registrant as Specified in Charter)
     
Florida
000-22904
59-2971472
(State or Other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
 
   
4446-1A Hendricks Avenue Suite 354, Jacksonville, Florida
32207
(Address of Principal Executive Offices)
(Zip Code)
 
(904) 732-6100
(Registrant’s Telephone Number, Including Area Code)
 
N/A
(Former Name or Former Address, if Changed Since Last Report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of Each Class
Trading Symbol
Name of Each Exchange on Which Registered
None
 
 
 
 
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter.
 
Emerging growth company   
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐
 
 

 
 
Item 8.01 Other Events
 
On January 30, 2025,  ParkerVision, Inc. (the “Company”) issued a press release announcing the release of the first episode in a four-part video series that provides an in-depth look into the Company's ongoing legal battle against Qualcomm.   A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.
 
The information contained in this Current Report on Form 8-K, including Exhibit 99.1 hereto, has been “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that section. The information in this Current Report shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.
 
Item 9.01. Financial Statements and Exhibits.
 
(d) Exhibits:
 
Exhibit Description
99.1 Press Release
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 

 
 
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
Dated: January 30 ,2025
   
   
PARKERVISION, INC.
     
   
By /s/ Cynthia French
   
Cynthia French
   
Chief Financial Officer
 
 

 Exhibit 99.1

 

 

NEWS RELEASE

 

ParkerVision Launches Against the Giants Video Series

Highlighting Ongoing Litigation

 

JACKSONVILLE, Florida,

 

January 30, 2025 -- ParkerVision, Inc. (“the Company”) (OTCQB: PRKR) announced today the release of the first episode in its four-part video series, Against the Giants.  The series, available exclusively on the newly created @Against_Giants X (formerly Twitter) and Instagram pages, provides an in-depth look into ParkerVision’s ongoing legal battle against Qualcomm.

 

As part of its commitment to transparency, ParkerVision aims to inform stakeholders about the critical issues at the heart of the litigation and the broader implications for intellectual property rights and fair competition in the tech industry.

 

“Our goal with Against the Giants is to shed light on the facts of our case and offer a clear, compelling narrative that underscores the importance of protecting innovation,” said Jeffrey Parker, CEO of ParkerVision. “We believe this series will provide valuable insight for our investors, partners, and the broader public as we hope to schedule a trial in 2025.”

 

The first episode of Against the Giants is now live on @Against_Giants on X and Instagram, with subsequent episodes scheduled for release in the coming weeks.

 

For more information, follow @Against_Giants on X @ http://x.com/against_giants and Instagram @ http://instagram.com/against_giants.

 

 

About ParkerVision

 

ParkerVision, Inc. invents, develops and licenses advanced, proprietary radio-frequency (RF) technologies that empower wireless solution providers to create and market state-of-the-art wireless communication products. ParkerVision is actively involved in multiple patent enforcement actions in the U.S. to safeguard its patented technologies, which it believes are being broadly infringed upon by others. For more information, please visit www.parkervision.com. (PRKR-I)

 

Safe Harbor Statement

 

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended.  All statements, other than statements of historical fact, included or incorporated in this press release are forward-looking statements. The Company does not guarantee that it will actually achieve the plans, intentions or expectations disclosed in its forward-looking statements and you should not place undue reliance on the Company's forward-looking statements. 

 

Forward-looking statements involve risks and uncertainties, and actual results could vary materially from these forward-looking statements. There are a number of important factors that could cause the Company's actual results to differ materially from those indicated or implied by its forward-looking statements, including those important factors set forth under the caption "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 and disclosures in the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, June 30, 2024, and September 30, 2024, filed with the Securities and Exchange Commission.  Although the Company may elect to do so at some point in the future, the Company does not assume any obligation to update any forward-looking statement and it disclaims any intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.

 

Contact:

Tony Vignieri

Communications Director

tvignieri@parkervision.com

 

Media Contact:

media@parkervision.com

 
v3.24.4
Document And Entity Information
Jan. 30, 2025
Document Information [Line Items]  
Entity, Registrant Name PARKERVISION, INC.
Document, Type 8-K
Document, Period End Date Jan. 30, 2025
Entity, Incorporation, State or Country Code FL
Entity, File Number 000-22904
Entity, Tax Identification Number 59-2971472
Entity, Address, Address Line One 4446-1A Hendricks Avenue Suite 354
Entity, Address, City or Town Jacksonville
Entity, Address, State or Province FL
Entity, Address, Postal Zip Code 32207
City Area Code 904
Local Phone Number 732-6100
Soliciting Material false
Written Communications false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0000914139

ParkerVision (QB) (USOTC:PRKR)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more ParkerVision (QB) Charts.
ParkerVision (QB) (USOTC:PRKR)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more ParkerVision (QB) Charts.